Article
Picrorhiza II inhibits the progress of HNSCC tumors by reducing the expression of MARK4 in tumor cells to hinder macrophage infiltration and polarization
2026-05-26
Abstract excerpt
<title>Abstract</title> <p> <bold>Background</bold> The majority of HNSCC patients respond very poorly to first-line clinical treatment. The main reasons for this are the lack of sensitive biomarkers and the lack of effective drug candidates. <bold>Results</bold> We discovered that HNSCC tumors have the ability to evade the immune system by employing a particular cellular protein, namely MARK4. MARK4 facilita...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c7d2deca-fe73-59e0-8e50-f0d82bb62bd5
- DOI
- 10.21203/rs.3.rs-9643850/v1
